New patent for AMRYT drug MYCAPSSA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MYCAPSSA
Annual Drug Patent Expirations for MYCAPSSA

Mycapssa is a drug marketed by Amryt and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.

This drug has fifty-eight patent family members in twenty-five countries.

The generic ingredient in MYCAPSSA is octreotide acetate. Two suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top